[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-364367-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-364367-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","circrnf13-enhances-igf2bp1-phase-separation-mediated-itgb1-mrna-stabilization-in-an-m6a-dependent-manner-oral-cancer-cisplatinchemoresistance","CircRNF13 enhances IGF2BP1 phase separation-mediated ITGB1 mRNA stabilization in an m6A-dependent manner - Oral cancer cisplatinchemoresistance","","Oral cancer ranks among the most common head and neck malignancies, yet its etiology remains insufficiently defined. This study profiles circRNA expression in oral cancer and identifies circRNF13 as elevated in cells and tissues, linked to higher tumor grade and stage. In vitro and in vivo data show circRNF13 increases proliferation and tumor growth while reducing cisplatin sensitivity. Mechanistically, circRNF13 binds the m6A reader IGF2BP1, blocks ubiquitin-mediated degradation, promotes phase separation, and thereby stabilizes ITGB1 mRNA in an m6A-dependent way, supporting malignant progression and therapeutic potential.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/circrnf13-enhances-igf2bp1-phase-separation-mediated-itgb1-mrna-stabilization-in-an-m6a-dependent-manner-oral-cancer-cisplatinchemoresistance/364367/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/circrnf13-enhances-igf2bp1-phase-separation-mediated-itgb1-mrna-stabilization-in-an-m6a-dependent-manner-oral-cancer-cisplatinchemoresistance/364367.png","ImageObject",300,407,{"name":42,"@type":43},"Olivia Brown","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does circRNF13 play in oral cancer?","Question",{"text":63,"@type":64},"circRNF13 is elevated in oral cancer cells and tissues and correlates with higher tumor grade and stage. It promotes proliferation and tumor growth while decreasing sensitivity to cisplatin.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does circRNF13 affect IGF2BP1 at the molecular level?",{"text":68,"@type":64},"circRNF13 interacts with IGF2BP1, inhibits its ubiquitin-mediated degradation, and promotes IGF2BP1 phase separation formation.",{"name":70,"@type":61,"acceptedAnswer":71},"How does this mechanism influence ITGB1 mRNA and treatment response?",{"text":72,"@type":64},"IGF2BP1 phase separation enhances ITGB1 mRNA stability in an m6A-dependent manner, supporting malignant progression and contributing to cisplatin chemoresistance.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},364367,1790325333,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Xu etal. Molecular Cancer (2025) 24:36 Molecular Cancer  \n[https://doi.org/10.1186/s12943-025-02239-4](https://doi.org/10.1186/s12943-025-02239-4)  \nRESEARCH Open Access  \nCircRNF13 enhances IGF2BP1 phase separation-mediated ITGB1 mRNA stabilization in an m6A-dependent manner to promote oral cancer cisplatinchemoresistance  \nXuemeng Xu 1,2†, Qiu Peng 1,2†, Zongyao Ren 1,2, Yaqian Han 1,2, Xianjie Jiang 1,2, Zhu Wu 1,2, Shiming Tan 1, Wenjuan Yang 1, Linda Oyang 1,2, Xia Luo 1,2, Jinguan Lin 1,2, Longzheng Xia 1,2, Mingjing Peng 1,2, Nayiyuan Wu 1,2, Yanyan Tang 1,2, Hao Tian 1,2*, Yujuan Zhou 1,2* and Qianjin Liao3*  \nAbstract  \nOral cancer ranks among the most common malignancies within the head and neck region; however, its etiology remains inadequately understood despite substantial research advances in recent years. Many studies highlight the regulatory role of circular RNAs (circRNAs) in human cancers, suggesting their potential as cancer biomarkers. However, their specific mechanisms in oral cancer are not well understood. This study analyzed circRNAs expression in oral cancer, identifying circRNF13 (circbaseID: has_circ_ 0006801) as having elevated expression in oral cancer cells and tissues. Our study demonstrated that circRNF13 is correlated with increased tumor grade and stage in oral cancer. Results from both in vitro and in vivo experiments indicated that circRNF13 enhances cancer cell proliferation and tumor growth, while concurrently diminishing tumor sensitivity to cisplatin. Mechanistically, circRNF13 interacts with the m6A “reader” protein IGF2BP1, inhibiting its ubiquitin-mediated degradation and promoting its phase separation formation. Subsequently, circRNF13 augments the stability of ITGB1 mRNA via IGF2BP1 in a manner dependent on m6A modification. The m6A modification of ITGB1 mRNA is modulated by the phase separation of IGF2BP1, thereby promoting the malignant progression of oral cancer cells. This evidence positions circRNF13 as a crucial regulatory molecule in the pathogenesis of oral cancer and suggests its potential as a therapeutic target. This discovery enriches our understanding of the mechanistic role of circRNAs.  \n†Xuemeng Xu and Qiu Peng contributed equally to this work.  \n*Correspondence: Hao Tian [tianhao@hnca.org.cn](tianhao@hnca.org.cn)[ ](tianhao@hnca.org.cn)Yujuan Zhou [yujany_zhou@163.com](yujany_zhou@163.com)[ ](yujany_zhou@163.com)Qianjin Liao [march-on@126.com](march-on@126.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nXu et al. Molecular Cancer (2025) 24:36 Page 2 of 18  \nKeywords Oral cancer, circRNF13, IGF2BP1, Liquid-liquid phase separation, m6A  \nIntroduction  \nOral cancer represents one of the predominant malignancies within the head and neck region. Currently, the therapeutic modalities for oral cancer predominantly encompass surgical intervention, radiotherapy, chemotherapy, and t","cbCaiq2HrK9b8MbK","https://ap.wps.com/l/cbCaiq2HrK9b8MbK","pdf",8278218,18,"English","# Abstract\n# Introduction","[{\"question\":\"What role does circRNF13 play in oral cancer?\",\"answer\":\"circRNF13 is elevated in oral cancer cells and tissues and correlates with higher tumor grade and stage. It promotes proliferation and tumor growth while decreasing sensitivity to cisplatin.\"},{\"question\":\"How does circRNF13 affect IGF2BP1 at the molecular level?\",\"answer\":\"circRNF13 interacts with IGF2BP1, inhibits its ubiquitin-mediated degradation, and promotes IGF2BP1 phase separation formation.\"},{\"question\":\"How does this mechanism influence ITGB1 mRNA and treatment response?\",\"answer\":\"IGF2BP1 phase separation enhances ITGB1 mRNA stability in an m6A-dependent manner, supporting malignant progression and contributing to cisplatin chemoresistance.\"}]","CircRNF13 enhances IGF2BP1 phase separation-mediated ITGB1 mRNA stabilization in an m6A-dependent manner - Oral cancer cisplatinchemoresistance | PDF",1790157281,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f1d950c7c4406a2c27d4388f2f79e7c0.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ef0e2471d049a4d8d2dc66a328dbb761.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bbd2af61fcd1098d9ccd9c0c4fa1a759.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/59ce8fef36ca06a17bbaea93dcd18836.webp",980,1306]